Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss FDMT - 4D Molecular Therapeutics, Inc.
16 K
LAST VALUE
42.75%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR